Oral fish oil restores striatal dopamine release after traumatic brain injury

Neuroscience Letters

Volumn 496, Issue 3, 2011, Pages 168-171

  Shin, Samuel S ^a,b   Dixon, C Edward ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Docosahexaenoic acid; Dopamine; Eicosapentaenoic acid; Fish oil; Omega 3 fatty acid; Traumatic brain injury

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; FISH OIL; HOMOVANILLIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE RELEASE; EVOKED RESPONSE; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BRAIN INJURIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; EXTRACELLULAR SPACE; FATTY ACIDS, OMEGA-3; FISH OILS; HOMOVANILLIC ACID; MALE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL;

EID: 79955841514     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.009     Document Type: Article

References (39)

1. Agut J., Ortiz J.A., Wurtman R.J. Cytidine (5′)diphosphocholine modulates dopamine K(+)-evoked release in striatum measured by microdialysis. Ann. N. Y. Acad. Sci. 2000, 920:332-335.
2. Aïd S., Vancassel S., Poumès-Ballihaut C., Chalon S., Guesnet P., Lavialle M. Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J. Lipid Res. 2003, 44:1545-1551.
3. Aïd S., Vancassel S., Linard A., Lavialle M., Guesnet P. Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J. Nutr. 2005, 135:1008-1013.
4. Bailes J.E., Mills J.D. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J. Neurotrauma 2010, 27:1617-1624.
5. Bailes J.E., Mills J.D., Hadley K. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury?. Neurosurgery 2011, January 5 (Epub ahead of print).
6. Bazan N.G. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J. Lipid Res. 2009, 50(April (Suppl.)):S400-S405.
7. Belayev L., Khoutorova L., Atkins K.D., Bazan N.G. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009, 40(September (9)):3121-3126.
8. Bousquet M., Saint-Pierre M., Julien C., Salem N., Cicchetti F., Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 2008, 22:1213-1225.
9. Bousquet M., Gibrat C., Saint-Pierre M., Julien C., Calon F., Cicchetti F Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(November (8)):1401-1408.
10. Cansev M., Wurtman R.J., Sakamoto T., Ulus I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement. 2008, 4(1 Suppl. 1):S153-S168.
11. Choi-Kwon S., Park K.A., Lee H.J., Park M.S., Lee J.H., Jeon S.E., Choe M.A., Park K.C. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Brain Res. Dev. Brain Res. 2004, 152:11-18.
12. Corrigan F.M., Horrobin D.F., Skinner E.R., Besson J.A., Cooper M.B. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int. J. Biochem. Cell Biol. 1998, 30:197-207.
13. Dangour A.D., Allen E., Elbourne D., Fasey N., Fletcher A.E., Hardy P., Holder G.E., Knight R., Letley L., Richards M., Uauy R. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am. J. Clin. Nutr. 2010, 91(June (6)):1725-1732.
14. Delattre A.M., Kiss A., Szawka R.E., Anselmo-Franci J.A., Bagatini P.B., Xavier L.L., Rigon P., Achaval M., Iagher F., de David C., Marroni N.A., Ferraz A.C. Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease. Neurosci. Res. 2010, 66(March (3)):256-264. Epub 2009 Nov 24.
15. Dixon C.E., Clifton G.L., Lighthall J.W., Yaghmai A.A., Hayes R.L. A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 1991, 39:253-262.
16. Dixon C.E., Ma X., Marion D.W. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res. 1997, 749:127-130.
17. Favreliere S., Perault M.C., Huguet F., De Javel D., Bertrand N., Piriou A., Durand G. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol. Aging 2003, 24:233-243.
18. Green D., Barreres L., Borensztajn J., Kaplan P., Reddy M.N., Rovner R., Simon H. A double-blind, placebo-controlled trial of fish oil concentrate (MaxEpa) in stroke patients. Stroke 1985, 16(July-August (4)):706-709.
19. Huang W.L., King V.R., Curran O.E., Dyall S.C., Ward R.E., Lal N., Priestley J.V., Michael-Titus A.T. A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007, 130:3004-3019.
20. Kimura M. Role of basal ganglia in behavioral learning. Neurosci. Res. 1995, 22(July (4)):353-358.
21. King V.R., Huang W.L., Dyall S.C., Curran O.E., Priestley J.V., Michael-Titus A.T. Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 2006, 26:4672-4680.
22. Kodas E., Vancassel S., Lejeune B., Guilloteau D., Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J. Lipid Res. 2002, 43:1209-1219.
23. Korchounov A.M. Role of D1 and D2 receptors in the regulation of voluntary movements. Bull. Exp. Biol. Med. 2008, 146(July (1)):14-17.
24. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chiang N., Serhan C.N., Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 2003, 278:43807-43817.
25. Mills J.D., Bailes J.E., Sedney C.L., Hutchins H., Sears B. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J. Neurosurg. 2011, 114(January (1)):77-84.
26. Mura A., Feldon J. Spatial learning in rats is impaired after degeneration of the nigrostriatal dopaminergic system. Mov. Disord. 2003, 18(August (8)):860-871.
27. Pan H.C., Kao T.K., Ou Y.C., Yang D.Y., Yen Y.J., Wang C.C., Chuang Y.H., Liao S.L., Raung S.L., Wu C.W., Chiang A.N., Chen C.J. Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J. Nutr. Biochem. 2009, 20:715-725.
28. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:477-485.
29. Sarsilmaz M., Songur A., Ozyurt H., Kus I., Ozen O.A., Ozyurt B., Sogut S., Akyol O. Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:253-259.
30. Shin S.S., Bray E.R., Zhang C.Q., Dixon C.E. Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats. Brain Res. 2010, (Epub ahead of print).
31. Tanriover G., Seval-Celik Y., Ozsoy O., Akkoyunlu G., Savcioglu F., Hacioglu G., Demir N., Agar A. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease. Folia Histochem. Cytobiol. 2010, 48(September (3)):434-441.
32. Wainwrite P.E. Do essential fatty acids play a role in brain and behavioral development?. Neurosci. Biobehav. Rev. 1992, 16:193-205.
33. Wang X., Zhao X., Mao Z.Y., Wang X.M., Liu Z.L. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. Neuroreport 2003, 14(December (18)):2457-2461.
34. Wang L., Pooler A.M., Albrecht M.A., Wurtman R.J. Dietary uridine-5′-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J. Mol. Neurosci. 2005, 27:137-145.
35. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
36. Wurtman R.J., Cansev M., Sakamoto T., Ulus I.H. Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 2009, 29:59-87.
37. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., Chalon S. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci. Lett. 1998, 240:177-181.
38. Zimmer L., Delpal S., Guilloteau D., Aïoun J., Durand G., Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci. Lett. 2000, 284(April (1-2)):25-28.
39. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., Durand G., Chalon S. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am. J. Clin. Nutr. 2002, 75(April (4)):662-667.